Patient Recruitment Resumes in FibroGen Phase 2 Study of ... - Earthtimes (press release) PDF Print

In fact, only 5% of incident dialysis patients have received therapy with Erythropoiesis-Stimulating Agents (ESAs), the primary treatment for anemia of CKD, ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.